Get the Stockscreener App
64.24
1.85%
-1.21
Hologic Inc stock is traded at $64.24, with a volume of 2.01M.
It is down -1.85% in the last 24 hours and down -11.62% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$65.45
Open:
$65.75
24h Volume:
2.01M
Relative Volume:
0.91
Market Cap:
$14.85B
Revenue:
$4.03B
Net Income/Loss:
$789.50M
P/E Ratio:
19.29
EPS:
3.33
Net Cash Flow:
$1.15B
1W Performance:
-10.95%
1M Performance:
-11.62%
6M Performance:
-21.55%
1Y Performance:
-13.01%
1-Day Range:
$64.08
$66.07
1-Week Range:
$64.08
$73.07
52-Week Range:
$64.08
$84.67
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
64.24 | 14.85B | 4.03B | 789.50M | 1.15B | 3.33 |
|
ISRG
Intuitive Surgical Inc
|
586.44 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
229.25 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
90.12 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
236.27 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
321.21 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-03-25 | Downgrade | Needham | Buy → Hold |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Dec-10-24 | Reiterated | Needham | Buy |
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
The Shocking Fall of Hologic: What Investors Need to Know! - Jomfruland.net
Why Hologic (HOLX) Stock Went Down On Thursday? - Insider Monkey
Morgan Stanley Lowers Price Target on Hologic to $77 From $82, Keeps Equalweight Rating - Marketscreener.com
Decoding Hologic Inc (HOLX): A Strategic SWOT Insight - GuruFocus.com
Hologic’s Earnings Call: Mixed Outlook Amidst Growth and Challenges - TipRanks
Leerink Partners Downgrades Hologic (HOLX) - MSN
Hologic Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Hologic shares fall 3% as Q2 guidance disappoints - MSN
UBS Adjusts Price Target on Hologic to $80 From $84, Keeps Neutral Rating -February 06, 2025 at 11:08 am EST - Marketscreener.com
Hologic, Inc. (NASDAQ:HOLX) Q1 2025 Earnings Call Transcript - Insider Monkey
Hologic's Financial Performance: Meeting Expectations and Navigating Future RisksNews and Statistics - IndexBox, Inc.
Earnings call transcript: Hologic Q1 2025 sees EPS beat, revenue miss - MSN
Hologic Q1 Earnings Beat, Stock Falls on Dismal '25 Sales Guidance - Yahoo Finance
Hologic revenue increases 0.9% in Q1 2025 - Medical Buyer
Hologic Inc (HOLX) Q1 2025 Earnings Call Highlights: Strong Diag - GuruFocus.com
Hologic Inc (HOLX) Q1 2025 Earnings Call Highlights: Strong Diagnostics Growth Amid Breast ... - Yahoo Finance
Hologic, Inc. Reports Earnings Results for the First Quarter Ended December 28, 2024 - Marketscreener.com
Hologic: Fiscal Q1 Earnings Snapshot - mySA
Hologic Reports Modest Revenue Growth in Q1 2025 - TipRanks
Hologic outlines Q2 revenue guidance of $995M–$1.005B amid expected diagnostics growth - MSN
Hologic Inc (HOLX) Q1 2025 Earnings: EPS Beats Estimates at $0.87, Revenue Slightly Misses at $1,021.8 Million - GuruFocus.com
Hologic Announces Financial Results for First Quarter of Fiscal 2025 - BioSpace
Earnings call transcript: Hologic Q1 2025 sees EPS beat, revenue miss By Investing.com - Investing.com South Africa
Hologic Faces Revenue Dip Following Demand Drop And Supply Challenges - Finimize
AI and Advocacy Unite: Tackling Women’s Health Disparities with Hologic Mia Keeys - MarketScale
Hologic (HOLX) Q1 Earnings Surpass Estimates - MSN
Hologic Inc Reports Retreat In Q1 Bottom Line - Nasdaq
Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics - Yahoo Canada Finance
Hologic Q1 Earnings Assessment - Benzinga
Hologic: Fiscal Q1 Earnings Snapshot -February 05, 2025 at 04:13 pm EST - Marketscreener.com
Hologic earnings beat by $0.02, revenue fell short of estimates - Investing.com Canada
Hologic shares fall 3% as Q2 guidance disappoints By Investing.com - Investing.com UK
Hologic (NASDAQ:HOLX) Reports Q4 In Line With Expectations But Full-Year Sales Guidance Misses Expectations - Yahoo Finance
Earnings Flash (HOLX) HOLOGIC INC. Posts Q1 Revenue $1.02B, vs. FactSet Est of $1.02B - Marketscreener.com
Hologic Earnings: Mixed Results as Diagnostics Surge 5.1% While Breast Health Falters - StockTitan
The Zacks Analyst Blog Highlights Boston Scientific, Hologic, BioTechne, STERIS And Align - Barchart
Clinical Microbiology Market Generated Opportunities, Future - openPR
The Zacks Analyst Blog Highlights Boston Scientific, Hologic, BioTechne, STERIS and Align - Yahoo Finance
Hologic Announces End of Life for Fluoroscan InSight FD Mini C-ArmMinicarm.com Ensures Continued Support for Owners - Fort Worth Star-Telegram
RBC Trims Price Target on Hologic to $88 From $89, Keeps Sector Perform Rating -February 04, 2025 at 07:16 am EST - Marketscreener.com
Hologic, Inc. (NASDAQ:HOLX) Short Interest Up 6.4% in January - MarketBeat
Forsta AP Fonden Sells 3,900 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hantz Financial Services Inc. Lowers Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Robeco Institutional Asset Management B.V. Sells 107,053 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Needham cuts Hologic stock rating on growth concerns - MSN
Hologic (NASDAQ:HOLX) Downgraded by Needham & Company LLC to "Hold" - MarketBeat
5 Analysts Have This To Say About Hologic - Benzinga
Needham Downgrades Hologic to Hold From Buy -February 03, 2025 at 06:33 am EST - Marketscreener.com
Mount Yale Investment Advisors LLC Lowers Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Swedbank AB Has $91.68 Million Holdings in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Shares Bought by KBC Group NV - MarketBeat
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hologic Inc Stock (HOLX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Mitchell Essex D | Chief Operating Officer |
Dec 04 '24 |
Sale |
76.34 |
24,856 |
1,897,482 |
27,957 |
9.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):